Background:
Prevalence of vitamin D insufficiency is high in western countries and low vitamin D has been associated with neurovascular injury. To better understand how vitamin D status affects cerebral ischemic susceptibility we assess whether low serum 25-hydroxyvitamin D (25[OH]D), a marker of vitamin D status, is predictive of the ischemic infarct volume and whether it relates to a worse outcome.
Methods:
We retrospectively analyzed prospective consecutive acute ischemic stroke patients that were evaluated from January 2013 to January 2014 at a tertiary referral center. All patients (n=96) had MRI-proven acute ischemic stroke. Multivariable linear and logistic regression analyses were used to test whether vitamin D represents an independent predictors of infarct volume and poor 90-day outcome (modified Rankin Scale score of >2).
Results:
There was a significant inverse correlation between infarct volume and serum 25(OH)D concentration in patients with lacunar (r=-.438; p=0.025) as well as non-lacunar (r=-.399; p=0.001) infarcts. Patients with ≥30 ng/mL had smaller infarct volumes than those with <30 ng/mL (Figure). The association of 25(OH)D with ischemic infarct volume was independent of other known predictors of the infarct extent (p<0.001). After adjustment, lower vitamin D (trichotomized as ≥30 vs 29-20 vs <20 ng/mL) was associated with a poor 90-day outcome (OR 9.46, 95%-CI 1.90-47.11, p=0.006).
Conclusion:
Low vitamin D independently predicts larger infarct volumes and a poor outcome following ischemic stroke. Though causality remains to be proven, our results highlight the need to further explore vitamin D as a promising biomarker for cerebral ischemic vulnerability and potential target for stroke prevention.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.